Eisai – Withdrawal of Belviq®, Belviq XR (lorcaserin)
February 13, 2020 - The FDA announced the request to voluntarily withdraw Belviq, Belviq XR (lorcaserin) from the U.S. market because a safety clinical trial showed an increased occurrence of cancer. Eisai, the manufacturer, has submitted a request to voluntarily withdraw the drug.
Top